Reimbursement issues with interferon therapies

Semin Oncol. 1988 Oct;15(5 Suppl 5):54-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Cost Control
  • Fees and Charges
  • Humans
  • Insurance, Health, Reimbursement*
  • Interferons / therapeutic use*
  • Neoplasms / economics
  • Neoplasms / therapy
  • United States
  • United States Food and Drug Administration

Substances

  • Interferons